Showing results 41 to 56 of 56
< previous
Issue Date | Title | Author(s) |
2022-02-22 | Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. | Zhang, Y; Almazi, JG; Ong, HX; Johansen, MD; Ledger, S; Traini, D; Hansbro, PM; Kelleher, AD; Ahlenstiel, CL |
2014-01 | Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa | Pozzoli, M; Sonvico, F; Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM; Traini, D |
2020-08-21 | Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of size. | Landh, E; M Moir, L; Bradbury, P; Traini, D; M Young, P; Ong, HX |
2013-05-13 | Quercetin solid lipid microparticles: A flavonoid for inhalation lung delivery | Scalia, S; Haghi, M; Losi, V; Trotta, V; Young, PM; Traini, D |
2021-06 | Real-time quantitative monitoring of in vitro nasal drug delivery by a nasal epithelial mucosa-on-a-chip model. | Gholizadeh, H; Ong, HX; Bradbury, P; Kourmatzis, A; Traini, D; Young, P; Li, M; Cheng, S |
2018-08-01 | Repurposing of statins via inhalation to treat lung inflammatory conditions | Bradbury, P; Traini, D; Ammit, AJ; Young, PM; Ong, HX |
2016-11-16 | Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study | Martignoni, I; Trotta, V; Lee, WH; Loo, CY; Pozzoli, M; Young, PM; Scalia, S; Traini, D |
2013-05-01 | Salbutamol sulfate absorption across calu-3 bronchial epithelia cell monolayer is inhibited in the presence of common anionic NSAIDs | Mamlouk, M; Young, PM; Bebawy, M; Haghi, M; Mamlouk, S; Mulay, V; Traini, D |
2018-10-01 | A Simple and Rapid Method for Deposition and Measurement of Drug Transport Across Air Interface Respiratory Epithelia | Haghi, M; Young, PM; Traini, D |
2015-04-07 | A 'soft spot' for drug transport: Modulation of cell stiffness using fatty acids and its impact on drug transport in lung model | Haghi, M; Traini, D; Wood, LG; Oliver, B; Young, PM; Chrzanowski, W |
2014-08 | SYNTHESIS OF CURCUMIN NANOPARTICLES FOR LUNG CANCER THERAPY | Lee, W-H; Ong, H-X; Loo, C-Y; Traini, D; Young, PM; Luk, F; Bebawy, M; Rohanizadeh, R |
2010-10-01 | Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model | Haghi, M; Young, PM; Traini, D; Jaiswal, R; Gong, J; Bebawy, M |
2022-06 | Timothy Grass Pollen Induces Spatial Reorganisation of F-Actin and Loss of Junctional Integrity in Respiratory Cells. | Bradbury, P; Cidem, A; Mahmodi, H; Davies, JM; Spicer, PT; Prescott, SW; Kabakova, I; Ong, HX; Traini, D |
2021-07-05 | Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line. | Sheikh, Z; Bradbury, P; Reekie, TA; Pozzoli, M; Robinson, PD; Kassiou, M; Young, PM; Ong, HX; Traini, D |
2014-01-01 | Towards the bioequivalence of pressurised metered dose inhalers 1: Design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient | Lewis, DA; Young, PM; Buttini, F; Church, T; Colombo, P; Forbes, B; Haghi, M; Johnson, R; O'Shea, H; Salama, R; Traini, D |
2014-01-01 | Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro | Haghi, M; Bebawy, M; Colombo, P; Forbes, B; Lewis, DA; Salama, R; Traini, D; Young, PM |